Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
126.20    -0.40 (-0.32%)
Bid:
125.20
Ask:
125.80
Spread: 0.60 (0.479%)
Market Cap: £307.19m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

6 Feb 2024 07:00

RNS Number : 0913C
PureTech Health PLC
06 February 2024
 

6 February 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

5 February 2024

Number of ordinary shares purchased:

67,637

Highest price paid per share:

194.40p

Lowest price paid per share:

189.00p

Volume weighted average price paid per share:

190.35p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 19,417,605 ordinary shares in treasury and has 270,050,554 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,050,554 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

05/02/2024

08:10:54

542

194.4

XLON

00388476624TRLO0.1.1

05/02/2024

08:30:10

790

192.8

XLON

00388480894TRLO0.1.1

05/02/2024

08:30:10

1920

193

XLON

00388480895TRLO0.1.1

05/02/2024

08:33:22

100

191.8

XLON

00388481869TRLO0.1.1

05/02/2024

08:33:22

442

191.8

XLON

00388481870TRLO0.1.1

05/02/2024

08:39:26

1200

191.2

XLON

00388483562TRLO0.1.1

05/02/2024

08:39:26

600

191.2

XLON

00388483561TRLO0.1.1

05/02/2024

08:39:26

368

191.2

XLON

00388483563TRLO0.1.1

05/02/2024

08:59:36

19

192.4

XLON

00388489022TRLO0.1.1

05/02/2024

09:08:37

233

192.4

XLON

00388491619TRLO0.1.1

05/02/2024

09:08:38

233

191.8

XLON

00388491623TRLO0.1.1

05/02/2024

09:08:38

311

191.8

XLON

00388491624TRLO0.1.1

05/02/2024

09:08:38

184

191.8

XLON

00388491626TRLO0.1.1

05/02/2024

09:08:38

542

191.8

XLON

00388491625TRLO0.1.1

05/02/2024

09:08:38

2168

191.8

XLON

00388491627TRLO0.1.1

05/02/2024

09:08:44

119

192.2

XLON

00388491650TRLO0.1.1

05/02/2024

09:44:20

146

191.4

XLON

00388500718TRLO0.1.1

05/02/2024

09:44:20

54

191.4

XLON

00388500719TRLO0.1.1

05/02/2024

09:44:20

295

191.4

XLON

00388500720TRLO0.1.1

05/02/2024

09:44:20

523

191.4

XLON

00388500721TRLO0.1.1

05/02/2024

09:44:20

495

191.4

XLON

00388500722TRLO0.1.1

05/02/2024

09:44:20

542

191.4

XLON

00388500723TRLO0.1.1

05/02/2024

09:44:20

1198

191.4

XLON

00388500724TRLO0.1.1

05/02/2024

09:44:20

428

191.4

XLON

00388500725TRLO0.1.1

05/02/2024

09:44:20

1034

191.4

XLON

00388500726TRLO0.1.1

05/02/2024

09:44:20

119

191.2

XLON

00388500727TRLO0.1.1

05/02/2024

09:51:50

233

189

XLON

00388502689TRLO0.1.1

05/02/2024

09:51:50

2168

189

XLON

00388502690TRLO0.1.1

05/02/2024

09:54:00

471

189

XLON

00388503128TRLO0.1.1

05/02/2024

09:54:00

80

189

XLON

00388503130TRLO0.1.1

05/02/2024

09:54:00

41

189

XLON

00388503129TRLO0.1.1

05/02/2024

10:45:50

39

189.6

XLON

00388517976TRLO0.1.1

05/02/2024

11:52:50

47

190.8

XLON

00388536893TRLO0.1.1

05/02/2024

11:54:45

747

190.8

XLON

00388537416TRLO0.1.1

05/02/2024

11:54:56

27

190.8

XLON

00388537449TRLO0.1.1

05/02/2024

12:09:20

35

190.8

XLON

00388540689TRLO0.1.1

05/02/2024

12:15:45

92

190.4

XLON

00388542478TRLO0.1.1

05/02/2024

12:33:45

31

191

XLON

00388546677TRLO0.1.1

05/02/2024

12:36:57

77

191

XLON

00388547444TRLO0.1.1

05/02/2024

12:59:25

11

190.6

XLON

00388552714TRLO0.1.1

05/02/2024

12:59:25

42

190.6

XLON

00388552715TRLO0.1.1

05/02/2024

13:08:38

24

190.8

XLON

00388555331TRLO0.1.1

05/02/2024

13:08:38

131

190.8

XLON

00388555332TRLO0.1.1

05/02/2024

13:08:40

118

190.8

XLON

00388555358TRLO0.1.1

05/02/2024

13:09:14

13

190.8

XLON

00388555527TRLO0.1.1

05/02/2024

13:09:46

69

190.8

XLON

00388555900TRLO0.1.1

05/02/2024

13:09:56

12

190.8

XLON

00388555964TRLO0.1.1

05/02/2024

13:10:13

222

190.6

XLON

00388556103TRLO0.1.1

05/02/2024

13:10:13

495

190.6

XLON

00388556104TRLO0.1.1

05/02/2024

13:10:13

542

190.6

XLON

00388556105TRLO0.1.1

05/02/2024

13:10:13

1299

190.6

XLON

00388556106TRLO0.1.1

05/02/2024

13:10:13

15

190.6

XLON

00388556107TRLO0.1.1

05/02/2024

13:10:13

1322

190.6

XLON

00388556109TRLO0.1.1

05/02/2024

13:10:13

789

190.6

XLON

00388556108TRLO0.1.1

05/02/2024

13:10:13

119

190.6

XLON

00388556110TRLO0.1.1

05/02/2024

13:25:26

1626

190.2

XLON

00388560158TRLO0.1.1

05/02/2024

13:25:26

1022

190.2

XLON

00388560159TRLO0.1.1

05/02/2024

13:25:28

152

190.6

XLON

00388560171TRLO0.1.1

05/02/2024

13:25:55

109

189.8

XLON

00388560255TRLO0.1.1

05/02/2024

13:33:10

162

189.8

XLON

00388562306TRLO0.1.1

05/02/2024

13:33:10

881

189.8

XLON

00388562307TRLO0.1.1

05/02/2024

13:33:10

89

189.8

XLON

00388562308TRLO0.1.1

05/02/2024

13:33:10

54

189.8

XLON

00388562309TRLO0.1.1

05/02/2024

13:33:10

25

189.8

XLON

00388562310TRLO0.1.1

05/02/2024

13:33:10

91

189.8

XLON

00388562311TRLO0.1.1

05/02/2024

13:33:10

2168

189.8

XLON

00388562312TRLO0.1.1

05/02/2024

14:38:07

542

190

XLON

00388594295TRLO0.1.1

05/02/2024

14:53:19

233

190.6

XLON

00388612077TRLO0.1.1

05/02/2024

14:53:19

233

190.6

XLON

00388612078TRLO0.1.1

05/02/2024

14:53:19

555

190.6

XLON

00388612079TRLO0.1.1

05/02/2024

14:53:19

385

190.4

XLON

00388612080TRLO0.1.1

05/02/2024

14:53:19

157

190.4

XLON

00388612081TRLO0.1.1

05/02/2024

14:53:19

119

190.4

XLON

00388612083TRLO0.1.1

05/02/2024

14:53:19

542

190.6

XLON

00388612082TRLO0.1.1

05/02/2024

14:53:19

119

190.4

XLON

00388612084TRLO0.1.1

05/02/2024

15:00:11

42

190.6

XLON

00388619026TRLO0.1.1

05/02/2024

15:04:40

500

190.6

XLON

00388624587TRLO0.1.1

05/02/2024

15:04:40

53

190.6

XLON

00388624588TRLO0.1.1

05/02/2024

15:04:40

489

190.6

XLON

00388624589TRLO0.1.1

05/02/2024

15:19:06

233

189.8

XLON

00388645674TRLO0.1.1

05/02/2024

15:19:06

1626

189.8

XLON

00388645675TRLO0.1.1

05/02/2024

15:19:06

1034

189.8

XLON

00388645676TRLO0.1.1

05/02/2024

15:47:25

465

190.4

XLON

00388669633TRLO0.1.1

05/02/2024

15:47:25

408

190.2

XLON

00388669634TRLO0.1.1

05/02/2024

15:47:25

370

190.2

XLON

00388669635TRLO0.1.1

05/02/2024

15:47:25

2710

190.4

XLON

00388669636TRLO0.1.1

05/02/2024

15:47:25

119

190.2

XLON

00388669637TRLO0.1.1

05/02/2024

15:47:25

41

190.2

XLON

00388669638TRLO0.1.1

05/02/2024

15:47:40

174

190

XLON

00388669811TRLO0.1.1

05/02/2024

15:54:47

2710

189

XLON

00388675886TRLO0.1.1

05/02/2024

15:55:05

399

189.8

XLON

00388676356TRLO0.1.1

05/02/2024

15:55:57

2710

190

XLON

00388677308TRLO0.1.1

05/02/2024

16:04:59

1400

189.8

XLON

00388684880TRLO0.1.1

05/02/2024

16:21:07

60

189.4

XLON

00388697549TRLO0.1.1

05/02/2024

16:25:29

482

189.4

XLON

00388701010TRLO0.1.1

05/02/2024

16:25:29

98

189.4

XLON

00388701011TRLO0.1.1

05/02/2024

16:25:29

30

189.4

XLON

00388701018TRLO0.1.1

05/02/2024

16:27:03

397

189.4

XLON

00388702217TRLO0.1.1

05/02/2024

16:27:03

171

189.4

XLON

00388702218TRLO0.1.1

05/02/2024

16:27:03

88

189.4

XLON

00388702219TRLO0.1.1

05/02/2024

16:27:03

139

189.4

XLON

00388702220TRLO0.1.1

05/02/2024

16:27:03

86

189.4

XLON

00388702221TRLO0.1.1

05/02/2024

16:27:09

15

189.8

XLON

00388702349TRLO0.1.1

05/02/2024

16:27:14

1203

189.8

XLON

00388702405TRLO0.1.1

05/02/2024

16:27:14

41

189.8

XLON

00388702406TRLO0.1.1

05/02/2024

16:29:18

46

189.2

XLON

00388704106TRLO0.1.1

05/02/2024

16:29:25

32

189.2

XLON

00388704194TRLO0.1.1

05/02/2024

16:29:44

479

189.8

XLON

00388704830TRLO0.1.1

05/02/2024

16:29:44

479

189.8

XLON

00388704832TRLO0.1.1

05/02/2024

16:29:44

2609

189.8

XLON

00388704831TRLO0.1.1

05/02/2024

16:29:44

3088

189.8

XLON

00388704833TRLO0.1.1

05/02/2024

16:29:45

310

189.8

XLON

00388704849TRLO0.1.1

05/02/2024

16:29:45

33

189.8

XLON

00388704850TRLO0.1.1

05/02/2024

16:29:45

690

189.8

XLON

00388704851TRLO0.1.1

05/02/2024

16:29:45

1000

189.8

XLON

00388704852TRLO0.1.1

05/02/2024

16:29:45

1000

189.8

XLON

00388704853TRLO0.1.1

05/02/2024

16:29:45

55

189.8

XLON

00388704854TRLO0.1.1

05/02/2024

16:29:45

945

189.8

XLON

00388704855TRLO0.1.1

05/02/2024

16:29:45

1000

189.8

XLON

00388704856TRLO0.1.1

05/02/2024

16:29:45

1000

189.8

XLON

00388704857TRLO0.1.1

05/02/2024

16:29:45

1000

189.8

XLON

00388704861TRLO0.1.1

05/02/2024

16:29:45

77

189

XLON

00388704862TRLO0.1.1

05/02/2024

16:29:45

88

189.8

XLON

00388704863TRLO0.1.1

05/02/2024

16:29:45

542

189.8

XLON

00388704864TRLO0.1.1

05/02/2024

16:29:45

292

189.8

XLON

00388704865TRLO0.1.1

05/02/2024

16:29:46

1

189.8

XLON

00388704920TRLO0.1.1

05/02/2024

16:29:46

190

189.8

XLON

00388704928TRLO0.1.1

05/02/2024

16:29:46

1208

189.8

XLON

00388704931TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLAFTIEIIS
Date   Source Headline
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
21st Aug 202512:00 pmRNS-RPureTech Showcases Differentiated IPF Strategy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.